Recursos

Esta seção contém pesquisas internacionais e pode fazer referência a indicações que não são aprovadas em todas as regiões. Consulte as indicações aprovadas localmente antes do uso.

Filtrar por:

Pesquisar

Click On The Read More Below To Request The Document

Click On The Read More Below To Request The Document

Click on the read more below to request the document

OMER, Israel, Feb 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month

We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo

Notícias da Pulse

Convidamos você a se manter atualizado com as últimas novidades, inscrevendo-se no nosso boletim informativo trimestral

Perguntas Freqentes

Perguntas Freqentes